Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Nederlands Tijdschrift Voor Geneeskunde
|
July 31, 2019
[A man with fever following laparotomy]
Hans Bezstarosti, Guy H E J Vijgen, Gaston J H Franssen
Nederlands Tijdschrift Voor Geneeskunde
|
March 19, 2020
[Small bowel neuroendocrine tumours: to be considered in the differential diagnosis of unexplained abdominal pain and diarrhoea]
Gaston J H Franssen, Tessa M van Ginhoven, Johannes Hofland, et al.
Updates in Surgery
|
December 6, 2024
Outcomes after adrenalectomy in elderly patients; a propensity score matched analysis
Charlotte L Viëtor, Inge S van Egmond, Gaston J H Franssen, et al.
Endocrine-Related Cancer
|
December 9, 2024
Primary tumour resection in metastasised adrenocortical carcinoma
Charlotte L Viëtor, Ivo J Schurink, Dirk J Grünhagen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 6, 2019
The Efficacy of Mitotane in Human Primary Adrenocortical Carcinoma Cultures
Peter M van Koetsveld, Sara G Creemers, Fadime Dogan, et al.
Cancers
|
January 28, 2021
Evolution of the Mesenteric Mass in Small Intestinal Neuroendocrine Tumours
Anela Blažević, Tessa Brabander, Wouter T Zandee, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 5, 2021
Levoketoconazole, the 2S,4R Enantiomer of Ketoconazole, a New Steroidogenesis Inhibitor for Cushing's Syndrome Treatment
Sara G Creemers, Richard A Feelders, Frank H de Jong, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism
|
March 15, 2016
Peptide receptor radionuclide therapy of neuroendocrine tumours
Tessa Brabander, Jaap J M Teunissen, Casper H J Van Eijck, et al.
Endocrine-Related Cancer
|
October 8, 2020
Inferior outcome of neuroendocrine tumor patients negative on somatostatin receptor imaging
Julie Refardt, Wouter T Zandee, Tessa Brabander, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 26, 2019
Osilodrostat Is a Potential Novel Steroidogenesis Inhibitor for the Treatment of Cushing Syndrome: An In Vitro Study
Sara G Creemers, Richard A Feelders, Frank H de Jong, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Nederlands Tijdschrift Voor Geneeskunde
|
July 31, 2019
[A man with fever following laparotomy]
Hans Bezstarosti, Guy H E J Vijgen, Gaston J H Franssen
Nederlands Tijdschrift Voor Geneeskunde
|
March 19, 2020
[Small bowel neuroendocrine tumours: to be considered in the differential diagnosis of unexplained abdominal pain and diarrhoea]
Gaston J H Franssen, Tessa M van Ginhoven, Johannes Hofland, et al.
Updates in Surgery
|
December 6, 2024
Outcomes after adrenalectomy in elderly patients; a propensity score matched analysis
Charlotte L Viëtor, Inge S van Egmond, Gaston J H Franssen, et al.
Endocrine-Related Cancer
|
December 9, 2024
Primary tumour resection in metastasised adrenocortical carcinoma
Charlotte L Viëtor, Ivo J Schurink, Dirk J Grünhagen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 6, 2019
The Efficacy of Mitotane in Human Primary Adrenocortical Carcinoma Cultures
Peter M van Koetsveld, Sara G Creemers, Fadime Dogan, et al.
Cancers
|
January 28, 2021
Evolution of the Mesenteric Mass in Small Intestinal Neuroendocrine Tumours
Anela Blažević, Tessa Brabander, Wouter T Zandee, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 5, 2021
Levoketoconazole, the 2S,4R Enantiomer of Ketoconazole, a New Steroidogenesis Inhibitor for Cushing's Syndrome Treatment
Sara G Creemers, Richard A Feelders, Frank H de Jong, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism
|
March 15, 2016
Peptide receptor radionuclide therapy of neuroendocrine tumours
Tessa Brabander, Jaap J M Teunissen, Casper H J Van Eijck, et al.
Endocrine-Related Cancer
|
October 8, 2020
Inferior outcome of neuroendocrine tumor patients negative on somatostatin receptor imaging
Julie Refardt, Wouter T Zandee, Tessa Brabander, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 26, 2019
Osilodrostat Is a Potential Novel Steroidogenesis Inhibitor for the Treatment of Cushing Syndrome: An In Vitro Study
Sara G Creemers, Richard A Feelders, Frank H de Jong, et al.
Page
of 3